Skip to main navigation Skip to search Skip to main content

Cholinesterase inhibitors for the treatment of delirium in non-ICU settings

  • Shanshan Wu
  • , Zongwang Zhang*
  • , Tom Dening
  • , Sai Zhao
  • , Gillian Pinner
  • , Jun Xia
  • , Ailan Yu
  • , Daogui Yang
  • *Corresponding author for this work

Research output: Journal PublicationArticlepeer-review

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effectiveness and safety of cholinesterase inhibitors for treating established delirium in people in a non-ICU setting.

Original languageEnglish
Article numberCD012494
JournalCochrane Database of Systematic Reviews
Volume2017
Issue number1
DOIs
Publication statusPublished - 11 Jan 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Cholinesterase inhibitors for the treatment of delirium in non-ICU settings'. Together they form a unique fingerprint.

Cite this